Apply to trial NCT07332182

A few quick questions so the study team can decide if you might be a fit.

RecruitingDevice study

MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee

The present study aims to compare the efficacy and the safety of MaioRegen Prime to Debridement (SSOC) in patients with deep osteochondral lesions of the knee joint. The foreseen population involves patients with osteochondral lesions with different etiology, dimension, shape, and location. The evaluation will be performed through clinical, subjective and objective assessments.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening